← Back to Clinical Trials
RecruitingNCT05631405

Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone (DengDex Study)

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionSevere Dengue
SponsorChulalongkorn University
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment200
SexALL
Min Age7 Years
Max Age99 Years
Start Date2022-10-16
Completion2025-12-31
Interventions
DexamethasonePlacebo

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this randomized double-blinded placebo-controlled trial is to learn about dexamethasone and the treatment of severe dengue population. The main question it aims to answer are steroid therapy may be effective in dengue.

Eligibility Criteria

Inclusion Criteria: * Laboratory confirmed Dengue infected patients (Positive NS1 Ag or anti-DENV IgM by Dengue Duo test) * And still in febrile phase (Body temp\>37.5 C) * Shock : Sys\<90mmHg or Narrow PP (\<20mmHg) orTachycardia (pulse\>100/min) with Hematocrit decreased ≥20 % * Fluid accumulation and respiratory distress * Severe bleeding * Severe organ involvement Exclusion Criteria: * Severe dengue\> 24 hrs * Dengue without warning signs * Pregnancy * Patient who receieved any steroid within 1 week

Related Trials